p53 and Ceramide as Collaborators in the Stress Response

被引:20
|
作者
Hage-Sleiman, Rouba [1 ,2 ]
Esmerian, Maria O. [1 ,2 ]
Kobeissy, Hadile [2 ]
Dbaibo, Ghassan [1 ,2 ]
机构
[1] Amer Univ Beirut, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Infect Dis, Beirut 11072020, Lebanon
[2] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon
关键词
ceramide; p53; apoptosis; sphingolipids; mitochondria; signaling; Bcl2; family; caspase; VASCULAR SMOOTH-MUSCLE; WILD-TYPE P53; NF-KAPPA-B; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; DAUNORUBICIN-INDUCED APOPTOSIS; RADIATION-INDUCED APOPTOSIS; ACTIVATED PROTEIN-KINASES; TUMOR-SUPPRESSOR P53; DE-NOVO SYNTHESIS; DNA-DAMAGE;
D O I
10.3390/ijms14034982
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sphingolipid ceramide mediates various cellular processes in response to several extracellular stimuli. Some genotoxic stresses are able to induce p53-dependent ceramide accumulation leading to cell death. However, in other cases, in the absence of the tumor suppressor protein p53, apoptosis proceeds partly due to the activity of this "tumor suppressor lipid", ceramide. In the current review, we describe ceramide and its roles in signaling pathways such as cell cycle arrest, hypoxia, hyperoxia, cell death, and cancer. In a specific manner, we are elaborating on the role of ceramide in mitochondrial apoptotic cell death signaling. Furthermore, after highlighting the role and mechanism of action of p53 in apoptosis, we review the association of ceramide and p53 with respect to apoptosis. Strikingly, the hypothesis for a direct interaction between ceramide and p53 is less favored. Recent data suggest that ceramide can act either upstream or downstream of p53 protein through posttranscriptional regulation or through many potential mediators, respectively.
引用
收藏
页码:4982 / 5012
页数:31
相关论文
共 50 条
  • [1] p53-dependent ceramide response to genotoxic stress
    Dbaibo, GS
    Pushkareva, MY
    Rachid, RA
    Alter, N
    Smyth, MJ
    Obeid, LM
    Hannun, YA
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (02) : 329 - 339
  • [2] Artemis is a negative regulator of p53 in response to oxidative stress
    Zhang, X.
    Zhu, Y.
    Geng, L.
    Wang, H.
    Legerski, R. J.
    ONCOGENE, 2009, 28 (22) : 2196 - 2204
  • [3] P53 mediates ceramide-induced apoptosis in SKN-SH cells
    Sung Su Kim
    Hee-Sun Chae
    Jae-Hyung Bach
    Myoung Woo Lee
    Kyung Yong Kim
    Won Bok Lee
    Young-Min Jung
    Joseph V Bonventre
    Yoo-Hun Suh
    Oncogene, 2002, 21 : 2020 - 2028
  • [4] P53 mediates ceramide-induced apoptosis in SKN-SH cells
    Kim, SS
    Chae, HS
    Bach, JH
    Lee, MW
    Kim, KY
    Lee, WB
    Jung, YM
    Bonventre, JV
    Suh, YH
    ONCOGENE, 2002, 21 (13) : 2020 - 2028
  • [5] Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment
    Struckhoff, Amanda P.
    Patel, Bhumi
    Beckman, Barbara S.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (01) : 21 - 30
  • [6] The mitochondrial p53 pathway
    Vaseva, Angelina V.
    Moll, Ute M.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2009, 1787 (05): : 414 - 420
  • [7] Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
    Lu, Phong
    Vander Mause, Erica R.
    Bowman, Katherine E. Redd
    Brown, Sarah M.
    Ahne, Lisa
    Lim, Carol S.
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [8] Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells
    Mojgan Mahyar-Roemer
    Claudia Fritzsche
    Sascha Wagner
    Michael Laue
    Klaus Roemer
    Oncogene, 2004, 23 : 6226 - 6236
  • [9] Ceramide Signaling and p53 Pathways
    Jeffries, Kristen A.
    Krupenko, Natalia I.
    SPHINGOLIPIDS IN CANCER, 2018, 140 : 191 - 215
  • [10] Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells
    Mahyar-Roemer, M
    Fritzsche, C
    Wagner, S
    Laue, M
    Roemer, K
    ONCOGENE, 2004, 23 (37) : 6226 - 6236